BackgroundCurrent methods of measuring disease progression of neurodegenerative disorders, including Parkinson's disease (PD), largely rely on composite clin...| Frontiers
V3 was DiMe’s first Tour of Duty. We launched the sprint effort in the fall of 2019 and published our manuscript in 2020 demonstrating our ability to deliver clinical quality work on a tech timeline.| DATAcc by DiMe
Explore Clario’s Opal®️ V2C precision motion monitoring and actigraphy solution for digital biomarker endpoint measurement in clinical trials.| Clario
By leveraging digital endpoints, clinical trials can be more patient-centric, data-driven, and adaptable to meet the evolving needs of healthcare research.| DATAcc by DiMe
DATAcc Projects DATAcc projects focus on advancing digital health measurements by developing new evidentiary frameworks and new measures in a pre-competitive environment. As a DATAcc project partner, you will be part of a project to transform lives with digital health measurement. Your organization will also become a member of the DATAcc steering committee and community. […]| DATAcc by DiMe
